Taysha Gene Therapies, Inc. Recorded Big Gain
Thu, Oct 02, 2025 at 08:30 PM
Taysha Gene Therapies, Inc. (TSHA:NASDAQ) shot up at $4.88, representing a gain of 53.5%. On Thu, Oct 02, 2025, TSHA:NASDAQ hit a New 2-Week High of $4.88. The stock appeared on our News Catalysts scanner on Thu, Oct 02, 2025 at 11:16 AM in the 'BIOTECH' category. From Thu, Sep 18, 2025, the stock recorded 60.00% Up Days and 63.64% Green Days
About Taysha Gene Therapies, Inc. (TSHA:NASDAQ)
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease.
Top 10 Gainers:
- Aspire Biopharma Holdings, Inc. (ASBP:NASDAQ), 95.71%
- Dragonfly Energy Holdings Corp. (DFLI:NASDAQ), 78.6%
- Concorde International Group Ltd. (CIGL:NASDAQ), 75.1%
- Boqii Holding Limited (BQ:NYSEMKT), 54.86%
- Taysha Gene Therapies, Inc. (TSHA:NASDAQ), 53.46%
- Borealis Foods Inc. (BRLS:NASDAQ), 53.35%
- SRAX, Inc. (SRAX:NASDAQ), 50%
- TNF Pharmaceuticals, Inc. (TNFA:NASDAQ), 48.15%
- Leap Therapeutics, Inc. (LPTX:NASDAQ), 38.81%
- Reviva Pharmaceuticals Holdings, Inc. (RVPH:NASDAQ), 35.12%